TabletsClinical Overview
Betahistine is a synthetic structural histamine analogue that acts as a strong antagonist at histamine H3 receptors and a weak agonist at histamine H1 receptors. By blocking H3 autoreceptors in the inner ear and vestibular nuclei, it enhances local histamine release, dilating precapillary sphincters in the stria vascularis and microvasculature of the labyrinth, thereby reducing endolymphatic hydrops pressure. Indicated for Meniere's disease (characterized by the triad of vertigo, tinnitus, and sensorineural hearing loss) and symptomatic vestibular vertigo.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with or after meals with a glass of water to reduce mild gastrointestinal discomfort. Regular daily intake over several weeks to months is required for sustained reduction in vertigo frequency.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Mild dyspepsia, nausea, headache, abdominal distention, mild cutaneous rash/pruritus. Rare/Severe: Severe hypersensitivity, angioedema, and bronchospasm in asthmatic patients.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with pheochromocytoma (risk of histamine-triggered hypertensive crisis). Use with caution in patients with bronchial asthma or active peptic ulcer disease. Concurrent antihistamines may reduce betahistine efficacy.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Betahistine Tablets 8 mg
Betahistine is a synthetic structural histamine analogue that acts as a strong antagonist at histamine H3 receptors and a weak agonist at histamine H1 receptors. By blocking H3 autoreceptors in the inner ear and vestibular nuclei, it enhances local histamine release, dilating precapillary sphincters in the stria vascularis and microvasculature of the labyrinth, thereby reducing endolymphatic hydrops pressure. Indicated for Meniere's disease (characterized by the triad of vertigo, tinnitus, and sensorineural hearing loss) and symptomatic vestibular vertigo.
Betahistine Tablets 16 mg
Betahistine is a synthetic structural histamine analogue that acts as a strong antagonist at histamine H3 receptors and a weak agonist at histamine H1 receptors. By blocking H3 autoreceptors in the inner ear and vestibular nuclei, it enhances local histamine release, dilating precapillary sphincters in the stria vascularis and microvasculature of the labyrinth, thereby reducing endolymphatic hydrops pressure. Indicated for Meniere's disease (characterized by the triad of vertigo, tinnitus, and sensorineural hearing loss) and symptomatic vestibular vertigo.